Intelligence / Healthtech / FDA 510(k) Clearances / Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc.
28 Aug 2026: Device cleared · cobas® Cdiff Nucleic acid test for use on the cobas® Liat® System (07454945190); cobas® Cdiff Positive and Negative Control Kit for use on the cobas® Liat® System (07454970190). Recorded in the openFDA device 510(k) data.
- Decided
- 28 Aug 2026
- Device
- cobas® Cdiff Nucleic acid test for use on the cobas® Liat® System (07454945190); cobas® Cdiff Positive and Negative Control Kit for use on the cobas® Liat® System (07454970190)
- Specialty
- Microbiology
- Country
- United States
- Location
- Pleasanton, CA
- Clearance type
- Traditional
- 510(k) number
- K260045
- Submitted
- 2026-01-07
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Find the decision makers at Roche Molecular Systems, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Roche Molecular Systems, Inc. in our registers.
More in Microbiology
FDA 510(k) Clearances
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.